Last edition
News about "CDMO"
Shilpa Biologicals has launched PartnerPower, a proprietary platform offering real-time visibility into process development and Good Manufacturing Practice (GMP) manufacturing, setting a new benchmark for transparency in CDMO operations.
CDMO | 24/06/2026 | By News Bureau
Made Scientific and Pluristyx Partner to Advance iPSC Cell Therapies
Made Scientific and Pluristyx have launched a strategic partnership to streamline iPSC-derived cell therapy development and manufacturing. By integrating Pluristyx’s clinical-grade iPSC platform with Made Scientific’s CDMO services, the collaboration provides developers with a single-source pathway from cell line development to commercial supply.
CDMO | 08/06/2026 | By News Bureau | 106
OrganaBio Acquires Excellos Assets to Establish Bicoastal Cell Therapy Manufacturing Platform
The acquisition expands cGMP manufacturing, PBMC isolation and cryopreservation capabilities across the US to support cell therapy developers from preclinical to commercial stages.
CDMO | 16/05/2026 | By News Bureau
OneSource and Orbicular Receive US FDA Tentative Approval for Generic Semaglutide
OneSource and Orbicular secure US FDA tentative approval for generic semaglutide injection, advancing ANDA filing for Ozempic with manufacturing support from OneSource.
CDMO | 22/04/2026 | By News Bureau | 196
Morepen Laboratories Bags Zero-Observation USFDA Inspection for Fourth Time
Morepen Laboratories clears its fourth consecutive USFDA inspection at the Masulkhana facility with zero observations (NIL 483), reinforcing its CDMO strength following a INR 825 crore global manufacturing mandate.
CDMO | 21/04/2026 | By News Bureau | 103
Piramal Pharma Solutions Expands ADC Capabilities with Ajinomoto Bio-Pharma Services Pact
Piramal Pharma Solutions partners with Ajinomoto Bio-Pharma Services to accelerate ADC development and manufacturing, enabling access to AJICAP technology.
CDMO | 20/04/2026 | By News Bureau | 121
Symbiosis Pharmaceutical Services Appoints Joanne Anderson as Chief Commercial Officer
Symbiosis Pharmaceutical Services has appointed Joanne Anderson as CCO, tasking her with leading global commercial strategy as the CDMO expands capacity and strengthens presence across North America and Europe.
CDMO | 13/03/2026 | By News Bureau | 124
Piramal Pharma Solutions Commercialises Tablet-in-Capsule Technology at Indian Manufacturing Sites
Piramal Pharma Solutions has successfully developed and commercialised a tablet-in-capsule drug delivery system in India, enabling flexible dosing, dual-release profiles and improved patient-centric oral therapies.
CDMO | 03/02/2026 | By News Bureau | 198
Agno Pharma Acquires Actylis's CDMO Manufacturing Asset
Agno Pharma has acquired Actylis’s CDMO manufacturing asset, the legacy Cascade Chemistry business based in Eugene, Oregon, strengthening Agno’s U. cGMP API development and manufacturing capabilities.
CDMO | 19/01/2026 | By News Bureau | 200
Rakuten Medical and LOTTE Biologics Sign Manufacturing Deal for Global Oncology Programme
Rakuten Medical has entered into a manufacturing agreement with LOTTE Biologics under which LOTTE Biologics will provide advanced manufacturing services for monoclonal antibody intermediates and their conjugates, supporting Rakuten Medical’s global clinical development programmes and future commercialisation in oncology.
CDMO | 19/01/2026 | By News Bureau | 204
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy